215 related articles for article (PubMed ID: 5115282)
1. Growth of leiomyomata with estrogen--progestogen therapy.
John AH; Martin R
J Reprod Med; 1971 Feb; 6(2):56-8. PubMed ID: 5115282
[No Abstract] [Full Text] [Related]
2. [More myomas caused by oral contraceptives?].
Eder M
MMW Munch Med Wochenschr; 1978 Dec; 120(50):1662. PubMed ID: 102973
[No Abstract] [Full Text] [Related]
3. [Oral contraceptives: update].
Fugère P
Union Med Can; 1983 Feb; 112(2):109-12. PubMed ID: 6845551
[No Abstract] [Full Text] [Related]
4. Estrogen use and endometrial cancer.
Greenblatt RB
N Engl J Med; 1979 Apr; 300(16):921-2. PubMed ID: 423940
[No Abstract] [Full Text] [Related]
5. Morphologic changes in the uterus associated with steroid contraceptives and intrauterine contraceptive devices.
Ober WB
Acta Cytol; 1970 Mar; 14(3):156. PubMed ID: 5265919
[No Abstract] [Full Text] [Related]
6. Oral contraceptives and endometrial and cervical cancer.
Moghissi KS
J Toxicol Environ Health; 1977 Sep; 3(1-2):243-65. PubMed ID: 336901
[No Abstract] [Full Text] [Related]
7. Relationship of estrogens and oral contraceptives to endometrial cancer in animals and women.
Drill VA
J Reprod Med; 1980 Jan; 24(1):5-13. PubMed ID: 6987399
[TBL] [Abstract][Full Text] [Related]
8. [Contraceptives. Side effects and risks].
García-Conti F
Rev Colomb Obstet Ginecol; 1971; 22(6):393-407. PubMed ID: 4947668
[No Abstract] [Full Text] [Related]
9. [Colpocytological patterns after prolonged treatment with combined estroprogestinic drugs].
Vernotico V; Zanella B
Minerva Ginecol; 1975 Jun; 27(6):448-56. PubMed ID: 1153121
[No Abstract] [Full Text] [Related]
10. Experimental and clinical aspects of the carcinogenic potential of steroid contraceptives.
Hertz R
Int J Fertil; 1968; 13(4):273-86. PubMed ID: 4882601
[No Abstract] [Full Text] [Related]
11. An internist's observations of patients on long-term contraception.
Cole SL
J Reprod Med; 1970 Oct; 5(4):175-8. PubMed ID: 5521940
[No Abstract] [Full Text] [Related]
12. [Oral contraception: uncertainties and prospects].
Mauvais-Jarvis P
Rev Prat; 1978 Sep; 28(41):3143-6, 3149-50, 3153-6. PubMed ID: 715351
[No Abstract] [Full Text] [Related]
13. Clinical evaluation of side effects of current oral contraceptives.
Nelson JH
J Reprod Med; 1971 Feb; 6(2):50-5. PubMed ID: 4255975
[No Abstract] [Full Text] [Related]
14. [A further case of hepatocytic adenoma following oestrogen-progestogen treatment. Review of the published literature (author's transl)].
Grandjean JP; Vignal J; Seffert P; Mestrallet G; Beurlet J; Quiviger P
Ann Chir; 1979 May; 33(5):361-70. PubMed ID: 389138
[No Abstract] [Full Text] [Related]
15. [Tolerance of the normocyclic sequence drug Oraconal and of various neutral hormones as well as of gestagen emphasizing contraceptive agents in the medical practice. Results of a group study of 173 established gynecologists involving 1539 women].
Erdmann G; Gelbhaar H; Pollter J
Fortschr Med; 1973 Mar; 91(7):303-10. PubMed ID: 4720458
[No Abstract] [Full Text] [Related]
16. Relationship between estrogen therapy and cancer.
Geller W
Mod Treat; 1968 May; 5(3):564-70. PubMed ID: 5690498
[No Abstract] [Full Text] [Related]
17. [On the side effects of treatment with hormone preparations consisting of estrogen-gestagen combinations].
Osler M
Ugeskr Laeger; 1967 Mar; 129(9):294-6. PubMed ID: 5599492
[No Abstract] [Full Text] [Related]
18. Maternal exposure to exogenous progestogen/estrogen as a potential cause of birth defects.
Nora AH; Nora JJ
Adv Plan Parent; 1978; 12(3):156-69. PubMed ID: 640221
[No Abstract] [Full Text] [Related]
19. [Lesions of the uterine cervix during oral contraception].
De Brux J
Sem Hop; 1974 May; 50(22):1491-5. PubMed ID: 4369604
[No Abstract] [Full Text] [Related]
20. Oral contraceptives: clinical problems and choices.
Jones DE; Halbert DR
Am Fam Physician; 1975 Oct; 12(4):115-23. PubMed ID: 1163414
[No Abstract] [Full Text] [Related]
[Next] [New Search]
